In support of its use as a negative prognostic marker in prostate cancer an investigation of 115 hormone naïve radical prostatectomy specimens demonstrated that higher tumour AR gene expression was associated with shorter time to biochemical recurrence [21]. The gene discussed is AR; the disease is neoplasm.